October 18th 2021, 12:40am
Panelists of a session at CHEST 2021 discuss the latest research regarding efficacy and safety of therapies in the management of asthma, including biologics, corticosteroids, and more.
October 17th 2021, 10:00pm
Evan L. Stepp, MD, FCCP, CPE, a pulmonologist at National Jewish Health, director of the Highlands Ranch Clinic, and an assistant professor, Department of Medicine, Division of Pulmonary, Critical Care and Sleep Medicine, discussed the recent FDA decision to authorize an e-cigarette intended to help current smokers quit combustible cigarettes.
October 17th 2021, 8:00pm
Mariam Lewis, MD, FCCP, a pulmonologist at UF Health and the UF College of Medicine, discusses why women are more sensitive to the effects of tobacco.
October 14th 2021, 8:45pm
The fall meeting has multiple sessions on different aspects of health disparities and addressing drug costs, including 3 sessions on biosimilars.
October 14th 2021, 8:33pm
Tackling disparities in diabetes management first requires collecting data and identifying affected groups before being able to take action, explained Brenden O'Hara, RPh, BCACP, from Blue Cross Blue Shield of North Carolina.
October 13th 2021, 7:00pm
Don Sin, MD, FRCP, MPH, who is presenting at CHEST 2021 on the topic of precision medicine and chronic obstructive pulmonary disease, discusses other topics of interest at CHEST 2021, which takes place virtually from October 17 to October 20, 2021.
October 13th 2021, 6:30pm
Compared with conferences held a year ago at this time, when vaccines were not yet available and the United States had yet to hit the peak of the pandemic, there are now more data to discuss about what we know and do not know about COVID-19.
October 8th 2021, 7:24pm
An overview of the significance of the Seema S. Sonnad Emerging Leader in Managed Care Research Award and why the early career achievements of this year's recipient, Christopher M. Whaley, PhD, in the field of managed care deserved recognition.
October 1st 2021, 3:00pm
The Oncology Care Model (OCM) was a great program that led to practice transformation and improved patient care, but there needs to be a way to address the high cost of cancer therapies, said Marcus Neubauer, MD, chief medical officer of the US Oncology Network.
September 25th 2021, 4:45pm
Experts who took part in Patient-Centered Oncology Care® 2021 said when guidelines recommend high-cost targeted therapies or immunotherapies, the focus must turn to areas such as imaging, diagnostic tests, and other elements that contribute to the cost of care.